Some have talked about phase 2 trials being high risk and that it’s hardly surprising it failed. I agree completely.
What’s really funny is they had mass produced a product with batch numbers and expiry dates ready to sell! And a strict quality assurance process..
They had produced millions of dollars of vials ready to sell and teamed up with distribution companies...
Talk about putting the cart before the horse... no wonder we all thought it couldn’t fail!! That’s why I believe we were all seriously misled..
Ann: Results of Phase 2 Clinical Trial, page-132
-
- There are more pages in this discussion • 25 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add DLM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $7.227M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
| DLM (ASX) Chart |
Day chart unavailable